Core Insights - Canada Nickel Company has successfully completed an in-situ carbon sequestration pilot study at its Crawford Nickel Project, demonstrating a new pathway for permanent CO2 storage [1] - The pilot project sequestered approximately 12 tonnes of CO2, indicating the potential for large-scale decarbonization in mining operations [1] Group 1: Project Details - The carbon sequestration pilot was conducted in collaboration with the U.S. Department of Energy's Advanced Research Projects Agency – Energy, led by the University of Texas at Austin [1] - The pilot involved short-duration injection trials and continuous CO2-saturated water injection into a well drilled to a depth of 396 meters, confirming that the injected CO2 remained dissolved without surface leakage [1] - Monitoring of seismicity and water chemistry will continue in the coming months to ensure the effectiveness of the carbon sequestration process [1] Group 2: Economic and Environmental Impact - The direct injection approach has the potential to lower future mining costs by pre-conditioning and fracturing the rock mass, making it less energy-intensive for subsequent mining processes [1] - The initiative is part of Canada Nickel's vision for a Zero-Carbon Industrial Cluster in the Timmins region, expanding the company's carbon capture and storage capabilities [1] - The results from this study will inform future post-mining carbon sequestration strategies, enhancing the environmental and economic value of mining operations [1]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 Centene Corporation (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of ...

Core Insights - Ambetter Health, in collaboration with KABOOM! and the City of Hialeah, has successfully completed a new playground at Southeast Park, built in a single day on January 30, 2026 [1] - The initiative aims to provide local children with a safe space for play, social interaction, and outdoor recreation, promoting healthier lifestyles [1] Company Overview - Ambetter Health is a product offered by Centene Corporation through the Health Insurance Marketplace, focusing on serving underserved populations [1] - The company emphasizes community engagement and health promotion through initiatives like the playground project [1] Partnership Details - The project marks the second collaboration between Ambetter Health, KABOOM!, and the City of Hialeah, following a successful playground build at Bucky Dent Park in 2019 [1] - KABOOM! is a national nonprofit dedicated to addressing playspace inequity, having created or transformed over 17,000 playspaces and ensuring access for more than 12 million children [1] Community Impact - The new playground is seen as an investment in children's health and happiness, with over 100 volunteers participating in its construction [1] - The City of Hialeah, which has a predominantly Hispanic population, aims to provide quality and affordable services to its residents, enhancing community well-being through such projects [1]

Core Insights - The article emphasizes the importance of unique insights and knowledge in stock analysis, aiming to provide contrasting views on investment portfolios [1] Group 1 - The analyst expresses a commitment to sharing personal opinions and insights without any financial compensation from the companies mentioned [2] - The analysis is intended solely for informational purposes, highlighting the necessity for investors to conduct their own research and due diligence [3] - There is a clear disclaimer that past performance does not guarantee future results, and no specific investment recommendations are made [4]

Core Insights - Centene Corporation reported a quarterly loss of $1.19 per share, which was better than the estimated loss of $1.22 per share [1][3] - The company's revenue for the quarter ending December 2025 was $49.73 billion, exceeding the estimated $48.41 billion and representing a 21.9% increase from the previous year's $40.81 billion [2][6] - For the full year 2025, Centene reported a GAAP diluted loss per share of $13.53, while the adjusted diluted earnings per share were $2.08, with projections for adjusted diluted earnings per share to exceed $3.00 in 2026 [4][6] Financial Performance - Centene's EPS of -$1.19 was a positive surprise compared to the Zacks Consensus Estimate of a $1.25 loss, marking a 4.76% positive deviation [3] - The company has consistently exceeded consensus revenue estimates over the past four quarters, demonstrating strong performance [2] - The Health Benefits Ratio (HBR) for the fourth quarter of 2025 was 94.3%, indicating improvements in Medicaid HBR [4][6] Financial Metrics - Centene's price-to-earnings (P/E) ratio is -3.55, and the price-to-sales ratio is 0.10, reflecting its current negative earnings situation [5] - The debt-to-equity ratio stands at 0.84, suggesting a moderate level of debt compared to equity [5] - A current ratio of 1.08 indicates that Centene maintains a reasonable level of short-term financial health [5]

Core Viewpoint - Centene Corporation reported a fourth-quarter adjusted loss despite revenue exceeding Wall Street expectations, primarily due to high costs in the Commercial segment, leading to a more than 6% drop in shares following the announcement [1]. Financial Performance - The company recorded an adjusted loss of $1.19 per share for the quarter, which was slightly better than analyst expectations of a $1.22 loss [2]. - Revenue increased by 23% year over year to $49.73 billion, surpassing the consensus estimate of $48.39 billion [2]. - The consolidated health benefits ratio (HBR) rose sharply to 94.3%, compared to 89.6% in the same quarter last year [2]. Segment Analysis - The Commercial segment had an HBR of 95.4%, which was approximately 100 basis points above company expectations due to net out-of-period items [3]. - The Medicaid segment showed improvement with an HBR of 93.0%, reflecting a 40-basis-point sequential improvement from the third quarter [3]. Future Guidance - For the full year 2025, Centene reported adjusted earnings of $2.08 per share on revenue of $194.78 billion, indicating a 20% increase compared to 2024 [4]. - The company provided guidance for 2026, projecting adjusted earnings per share of more than $3.00, demonstrating confidence in its recovery efforts [4].

Group 1 - The core focus of Crude Value Insights is on cash flow and companies that generate it, highlighting value and growth prospects in the oil and natural gas sector [1] - Subscribers benefit from a 50+ stock model account, which provides a comprehensive overview of investment opportunities [1] - The service includes in-depth cash flow analyses of exploration and production (E&P) firms, enhancing understanding of the sector's financial health [1] Group 2 - The platform offers a live chat discussion feature, fostering community engagement and real-time insights among subscribers [1] - A two-week free trial is available for new users, encouraging exploration of the oil and gas investment landscape [2]

Group 1 - The core focus of Crude Value Insights is on cash flow and companies that generate it, highlighting value and growth prospects in the oil and natural gas sector [1] - Subscribers benefit from a 50+ stock model account, which provides a comprehensive analysis of cash flow for exploration and production (E&P) firms [1] - The service includes live chat discussions about the sector, fostering a community for investors interested in oil and gas [1] Group 2 - A two-week free trial is available for new subscribers, encouraging engagement with the oil and gas investment community [2]

Core Insights - Centene Corporation (CNC) reported a fourth-quarter 2025 adjusted loss per share of $1.19, which was better than the Zacks Consensus Estimate of a loss of $1.25 per share, compared to adjusted earnings of 80 cents per share in the same quarter last year [1][9] - Total revenues reached $49.7 billion, reflecting a year-over-year increase of 21.9% and surpassing the consensus estimate by 3.1% [1][4] Revenue Breakdown - Medicaid revenues increased by 11% year over year to $23 billion, while Medicare revenues surged 75% year over year to $9.6 billion. Commercial revenues rose 24% year over year to $10.8 billion [3] - Premium revenues grew by 23.8% year over year to $44 billion, driven by higher premiums and membership in the PDP and Marketplace businesses, as well as Medicaid rate hikes, exceeding the Zacks Consensus Estimate of $43.5 billion [4] Membership and Costs - Total membership declined by 3.4% year over year to 27.6 million, missing the consensus mark of 27.9 million, primarily due to decreases in Medicaid and Medicare memberships [5] - The health benefits ratio worsened by 470 basis points year over year to 94.3%, with operating expenses rising 26.7% year over year to $51.5 billion, largely due to increased medical costs, which escalated by 30.4% year over year [6][9] Financial Position - As of December 31, 2025, Centene had cash and cash equivalents of $17.9 billion, a 27.2% increase from the end of 2024. Total assets decreased by 6.9% to $76.7 billion, while long-term debt fell by 5.8% to $17.4 billion [7] - The company generated $5.1 billion in net cash from operations in 2025, a significant increase from the previous year [8] Full-Year Performance - For the full year 2025, total revenues amounted to $194.8 billion, a 19.4% increase from 2024, while adjusted EPS dropped 71% year over year to $2.08. Premium and service revenues reached $174.6 billion, up 20% year over year [11] 2026 Guidance - Management projects premium and service revenues for 2026 to be between $170 billion and $174 billion, indicating a potential decline of 1.5% from 2025. Total revenues are expected to range from $186.5 billion to $190.5 billion, suggesting a 3.2% decrease from 2025 [12] - Adjusted EPS is anticipated to exceed $3.00, representing a 44.2% increase from 2025, while GAAP EPS is expected to remain above $1.98 [12]

Core Viewpoint - Centene Corporation's stock declined due to a mixed outlook for fiscal 2026, despite reporting better-than-expected earnings for Q4 2025 [1]. Earnings Snapshot - The company reported a fourth-quarter 2025 adjusted loss of $1.19 per share, which was better than the consensus loss of $1.22 per share, contrasting with an income of $0.80 per share a year ago [2]. - Centene's sales increased from $40.81 billion to $49.73 billion, surpassing the consensus estimate of $48.39 billion [2]. - The health benefits ratio (HBR) rose to 94.3%, up from 89.6% a year ago [2]. Membership and Costs - Total membership across Centene's portfolio decreased to 27.63 million from 28.60 million a year ago, mainly due to a drop in Medicaid membership from 13.00 million to 12.52 million [4]. - Commercial membership increased from 4.81 million to 5.99 million [4]. - The increase in HBR was primarily driven by higher Marketplace morbidity impacting medical costs and program changes in the PDP business due to the Inflation Reduction Act [3]. Management Commentary and Guidance - Centene anticipates adjusted earnings for fiscal 2026 to exceed $3 per share, compared to the consensus of $2.94 [5]. - The CEO stated that the company is positioned for significant margin improvement and renewed adjusted diluted EPS growth, aiming for adjusted diluted EPS greater than $3.00 in 2026 [6]. - The company expects 2026 sales to be between $186.5 billion and $190.5 billion, below the consensus of $193.43 billion, with premium revenues projected between $170 billion and $174 billion [7].